Fei Wang
My name is Fei Wang, a PhD student from the 2024 cohort, originally from Shandong. After graduation, I joined the Cell and Gene Therapy (CGT) industry, focusing on technical platform development, CMC, and portfolio management. It is a great honor to join DuLab. My future research will primarily explore the downstream applications of stem cells and their derivatives. Under the guidance of Professor Du and with the support of the DuLab platform, I aspire to leverage my expertise to contribute to the progress of our nation’s healthcare sector. In my spare time, I enjoy running, listening to E-Books, and music.